BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30075949)

  • 1. Genetics of primary macronodular adrenal hyperplasia.
    Candida Barisson Villares Fragoso M; Pontes Cavalcante I; Meneses Ferreira A; Marinho de Paula Mariani B; Ferini Pacicco Lotfi C
    Presse Med; 2018; 47(7-8 Pt 2):e139-e149. PubMed ID: 30075949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH).
    Charchar HLS; Fragoso MCBV
    J Endocr Soc; 2022 May; 6(5):bvac041. PubMed ID: 35402764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
    Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI; Nesterova M; Stratakis CA
    Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiopathogeny of Primary Adrenal Hypercortisolism.
    Vélayoudom-Céphise FL; Haissaguerre M; Tabarin A
    Front Horm Res; 2016; 46():39-53. PubMed ID: 27212135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GERMLINE DELETION OF ARMC5 IN FAMILIAL PRIMARY MACRONODULAR ADRENAL HYPERPLASIA.
    Suzuki S; Tatsuno I; Oohara E; Nakayama A; Komai E; Shiga A; Kono T; Takiguchi T; Higuchi S; Sakuma I; Nagano H; Hashimoto N; Mayama T; Koide H; Sasano H; Nakatani Y; Imamoto T; Ichikawa T; Yokote K; Tanaka T
    Endocr Pract; 2015 Oct; 21(10):1152-60. PubMed ID: 26214113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH).
    Cavalcante IP; Nishi M; Zerbini MCN; Almeida MQ; Brondani VB; Botelho MLAA; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Bertherat J; Lotfi CFP; Fragoso MCBV
    Mol Cell Endocrinol; 2018 Jan; 460():36-46. PubMed ID: 28676429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
    Albiger NM; Regazzo D; Rubin B; Ferrara AM; Rizzati S; Taschin E; Ceccato F; Arnaldi G; Pecori Giraldi F; Stigliano A; Cerquetti L; Grimaldi F; De Menis E; Boscaro M; Iacobone M; Occhi G; Scaroni C
    Endocrine; 2017 Mar; 55(3):959-968. PubMed ID: 27094308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.
    Alencar GA; Lerario AM; Nishi MY; Mariani BM; Almeida MQ; Tremblay J; Hamet P; Bourdeau I; Zerbini MC; Pereira MA; Gomes GC; Rocha Mde S; Chambo JL; Lacroix A; Mendonca BB; Fragoso MC
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1501-9. PubMed ID: 24708098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
    Almeida MQ; Stratakis CA
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):162-8. PubMed ID: 21111774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
    J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical tumorigenesis: Lessons from genetics.
    Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal Hyperplasia.
    Villares Fragoso MC; Wanichi IQ; Cavalcante IP; Mariani BM
    Front Endocrinol (Lausanne); 2016; 7():104. PubMed ID: 27512387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.
    Elbelt U; Trovato A; Kloth M; Gentz E; Finke R; Spranger J; Galas D; Weber S; Wolf C; König K; Arlt W; Büttner R; May P; Allolio B; Schneider JG
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E119-28. PubMed ID: 25279498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex.
    Horvath A; Giatzakis C; Tsang K; Greene E; Osorio P; Boikos S; Libè R; Patronas Y; Robinson-White A; Remmers E; Bertherat J; Nesterova M; Stratakis CA
    Eur J Hum Genet; 2008 Oct; 16(10):1245-53. PubMed ID: 18431404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.
    Bourdeau I; Oble S; Magne F; Lévesque I; Cáceres-Gorriti KY; Nolet S; Awadalla P; Tremblay J; Hamet P; Fragoso MC; Lacroix A
    Eur J Endocrinol; 2016 Jan; 174(1):85-96. PubMed ID: 26604299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
    Yu L; Zhang J; Guo X; Chen X; He Z; He Q
    PLoS One; 2018; 13(1):e0191602. PubMed ID: 29370219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.